Triasol Injection

Adult dosage

Adults: Administer by intravenous infusion 1 to 1.5 g of total amino acids per day per kg of body weight as the maximum dosage. Administration rate: A concentration of about 10 g of total amino acids is preferable over 60 minutes, ideally administering 30 to 40 drops per minute.

Children's dosage

In pediatric dosage, the dose and infusion rate should be adjusted.

This medication must be used strictly according to a doctor's instructions. It should not be used in patients with symptoms of hepatic encephalopathy or those at risk for hepatic encephalopathy. Patients with severe renal impairment or hyperazotemia should also not receive this medication. It is not suitable for patients with nitrogen metabolism disorders. Patients with severe heart failure, pulmonary edema, or very low or absent urine output should not use this medication. In cases containing sodium and chloride ions, it should not be administered to patients with hypernatremia, hyperchloremia, or alkalosis. Patients with a history of myocardial infarction may face risks with this medication. Use with caution in patients with severe acidosis or congestive heart failure, and those with edema due to sodium retention. If potassium levels are high or potassium is accumulated in the body, careful monitoring is necessary when using this medication. Patients with liver or kidney dysfunction require more careful monitoring when administered. Contains sodium bisulphite, which may cause serious allergic reactions, especially in asthmatic patients, so caution is warranted. Rarely, hypersensitivity reactions such as skin rashes may occur, so if unusual symptoms arise, administration should be stopped immediately. Gastrointestinal symptoms may include nausea or vomiting. Cardiac-related symptoms may include chest discomfort, palpitations, rapid heartbeat, and increased blood pressure. Rapid administration of large amounts increases the risk of acidosis. Chills, fever, headache, difficulty breathing, or in severe cases, respiratory arrest, shock, bronchospasm, and urinary tract spasms may occur. Metabolic complications can include acidosis, hypophosphatemia, alkalosis, elevated blood sugar, diabetes, dehydration, hypoglycemia, liver function abnormalities, vitamin imbalance, and electrolyte imbalance. Patients with liver or kidney dysfunction may see elevated blood urea nitrogen levels. Patients with very poor liver function may present with serious symptoms such as amino acid imbalance, metabolic alkalosis, and coma. Serious immunological reactions such as anaphylactic shock have been reported in association with this medication. When administering large amounts or using with other infusions containing electrolytes, careful monitoring of electrolyte balance is necessary. Overdosage may cause metabolic alkalosis, so one must check the included components carefully and use cautiously. Patients with a history of kidney, lung, or heart disease should avoid excessive fluid administration. Diabetic patients must check blood sugar levels frequently during administration. The protein-sparing effect of this medication may be reduced when used with tetracycline antibiotics. Safety has not been adequately confirmed for pregnant women, so it should only be administered when absolutely necessary. Pediatric patients may have immature liver function, so dosages should be maintained low and blood ammonia levels monitored frequently. Elderly patients have reduced physical function, so the rate of administration should be slow and the dose adjusted accordingly. This medication contains electrolytes, and rapid administration may cause chills or vomiting, so it should be infused slowly. It is recommended to warm the drug to body temperature before administration and to maintain strict aseptic preparation and handling. If the solution is discolored or leaks, it should not be used, and the packaging should remain unopened and used within 24 hours when refrigerated. Always check the condition of the container before use and discontinue use if any abnormalities are found.

Serious side effects

• Anaphylactic shock
• difficulty breathing
• respiratory arrest
• asthma attack.

Mild side effects

• Rash
• nausea
• vomiting
• chest discomfort
• palpitations
• rapid heartbeat
• increased blood pressure
• acidosis
• chills
• fever

This medication should be stored in a sealed container to prevent contact with air or moisture at room temperature. This will maintain its efficacy and prevent degradation.

Appearance

A colorless to pale yellow transparent liquid filled in a plastic container for injection.

Package unit

100 milliliters/bottle, 250 milliliters/bottle